Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Guidelines
Early-Stage and Locally Advanced (non-metastatic) Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines
eUpdate 04 May 2020: New Locally Advanced NSCLC Treatment Recommendations
These updated guidelines on early and locally advanced non-small-cell lung cancer focus on treatment recommendations including follow-up and survivorship. Also covered are new personalised medicine recommendations and new treatment algorithms for locoregional lymph node staging in patients with non-metastatic NSCLC and with clinical stage I lung cancer and limited pulmonary function due to emphysema.
Read full Guideline